Biogen Earnings Miss, Revenue Beats In Q1
2022.05.03 14:53
Biogen Earnings Miss, Revenue Beats In Q1
Investing.com – Biogen (NASDAQ:BIIB) reported on Tuesday first quarter earnings that missed analysts’ forecasts and revenue that topped expectations.
Biogen announced earnings per share of $3.62 on revenue of $2.53B. Analysts polled by Investing.com anticipated EPS of $4.34 on revenue of $2.5B.
Biogen shares are up 6.49% from the beginning of the year, still down 55.72% from its 52 week high of $468.20 set on June 7, 2021. They are outperforming the Nasdaq 100 which is down 19.88% from the start of the year.
Biogen follows other major Healthcare sector earnings this month
Biogen’s report follows an earnings beat by UnitedHealth on April 14, who reported EPS of $5.49 on revenue of $80.15B, compared to forecasts EPS of $5.36 on revenue of $78.73B.
J&J had beat expectations on April 19 with first quarter EPS of $2.67 on revenue of $23.43B, compared to forecast for EPS of $2.59 on revenue of $23.62B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
